X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC PHARMA ABBOTT INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 42.5 29.6 143.6% View Chart
P/BV x 10.6 6.8 157.2% View Chart
Dividend Yield % 0.6 0.7 90.7%  

Financials

 ABBOTT INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
ALEMBIC PHARMA
Mar-16
ABBOTT INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs6,015792 759.8%   
Low Rs3,707443 836.8%   
Sales per share (Unadj.) Rs1,236.9167.0 740.6%  
Earnings per share (Unadj.) Rs122.238.2 320.2%  
Cash flow per share (Unadj.) Rs129.042.0 307.1%  
Dividends per share (Unadj.) Rs35.004.00 875.0%  
Dividend yield (eoy) %0.70.6 111.1%  
Book value per share (Unadj.) Rs521.284.9 613.9%  
Shares outstanding (eoy) m21.25188.52 11.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.93.7 106.3%   
Avg P/E ratio x39.816.2 245.9%  
P/CF ratio (eoy) x37.714.7 256.4%  
Price / Book Value ratio x9.37.3 128.3%  
Dividend payout %28.610.5 273.3%   
Avg Mkt Cap Rs m103,296116,383 88.8%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3704,214 80.0%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,28431,487 83.5%  
Other income Rs m50455 915.4%   
Total revenues Rs m26,78931,542 84.9%   
Gross profit Rs m3,66510,060 36.4%  
Depreciation Rs m144722 20.0%   
Interest Rs m837 22.0%   
Profit before tax Rs m4,0179,356 42.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4212,160 65.8%   
Profit after tax Rs m2,5967,194 36.1%  
Gross profit margin %13.931.9 43.6%  
Effective tax rate %35.423.1 153.2%   
Net profit margin %9.922.8 43.2%  
BALANCE SHEET DATA
Current assets Rs m14,44615,066 95.9%   
Current liabilities Rs m4,7257,674 61.6%   
Net working cap to sales %37.023.5 157.6%  
Current ratio x3.12.0 155.7%  
Inventory Days Days5167 76.8%  
Debtors Days Days2041 48.1%  
Net fixed assets Rs m1,1138,237 13.5%   
Share capital Rs m213377 56.4%   
"Free" reserves Rs m10,80815,416 70.1%   
Net worth Rs m11,07616,005 69.2%   
Long term debt Rs m00-   
Total assets Rs m16,24124,594 66.0%  
Interest coverage x497.0255.2 194.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.61.3 126.4%   
Return on assets %16.029.4 54.5%  
Return on equity %23.444.9 52.1%  
Return on capital %36.358.7 61.9%  
Exports to sales %0.655.7 1.1%   
Imports to sales %12.610.4 121.2%   
Exports (fob) Rs m16217,551 0.9%   
Imports (cif) Rs m3,3223,283 101.2%   
Fx inflow Rs m26817,811 1.5%   
Fx outflow Rs m3,9275,318 73.9%   
Net fx Rs m-3,65912,493 -29.3%   
CASH FLOW
From Operations Rs m2,5149,304 27.0%  
From Investments Rs m-800-3,105 25.8%  
From Financial Activity Rs m-803-1,959 41.0%  
Net Cashflow Rs m9124,240 21.5%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.9 272.4%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 13.9 123.0%  
Shareholders   18,270 49,328 37.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare ABBOTT INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 16, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS